Pfizer: Osteoarthritis, Knee trials

The registry lists 17 Osteoarthritis, Knee studies with Pfizer as lead sponsor. 2 are open to participants now and 8 have results posted.

Phase 2 8Phase 3 8No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)RecruitingNCT07919678Phase 3
• A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)RecruitingNCT07915609Phase 3
• Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.CompletedNCT02709486Phase 3Results posted
• Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or KneeCompletedNCT02697773Phase 3Results posted
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or KneeCompletedNCT02528188Phase 3Results posted
• Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The KneeCompletedNCT01430559Not applicableResults posted
• A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The KneeTerminatedNCT01147458Phase 2Results posted
• A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous InjectionsTerminatedNCT00994890Phase 2Results posted
• Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The KneeCompletedNCT00689273Phase 2Results posted
• A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The KneeCompletedNCT00669409Phase 2Results posted
• X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The KneeWithdrawnNCT01438918Phase 3
• A Study of ARRY-371797 in Patients With Osteoarthritis of the KneeCompletedNCT01366014Phase 2
• Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the KneeCompletedNCT01102660Phase 2
• A Study To Investigate Whether PF-04457845 Is Effective In Treating Pain, Is Safe And Tolerable In Patients With Osteoarthritis Of The KneeCompletedNCT00981357Phase 2
• A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)CompletedNCT00650624Phase 2
• A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg Once Daily And Naproxen 500mg Twice Daily In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In TaiwanCompletedNCT00648258Phase 3
• Celebrex Short Versus Long Therapy In Osteoarthritis Of The KneeCompletedNCT00137410Phase 3